- Recent Funding
- Investors
- SightLine Partners
SSightLine Partners portfolio
SightLine Partners has 1 portfolio company on record at Recent Funding.
About this page
It is a fund of funds based in Bloomington, US. Its most recent investment on record is Monteris Medical's $26.6M Series B+ round in June 2017, which it led, alongside BDC Venture Capital, Versant Ventures and Birchview Fund. That company is in Health and bio.
About SightLine Partners
What SightLine Partners invests in
- Health and bio · 1 · 100%
How SightLine Partners invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $26.6M |
SightLine Partners portfolio companies
MMonteris Medical$26.6MSeries B+ · Jun 2017
| Company | Round with SightLine Partners | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $26.6M · lead | $68.3M | Mar 12, 2026 Series B+ |
Most frequent co-investors
BBDC Venture Capital1 shared round · last Jun 1, 2017
VVersant Ventures1 shared round · last Jun 1, 2017
BBirchview Fund1 shared round · last Jun 1, 2017
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 1 round on Recent Funding that name SightLine Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists SightLine Partners, which is a subset of its real portfolio. API: /api/v1/investors/sightline-partners (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy